Identification of a novel CDKL5 exon and pathogenic mutations in patients with severe mental retardation, early-onset seizures and Rett-like features

COMPOUNDS FOR THE TREATMENT OF CDKL5 DISORDER

Application WO-2017221127-A1

World Intellectual Property Organisation (WIPO)